Contrasting Mettler-Toledo International (NYSE:MTD) and Nautilus Biotechnology (NASDAQ:NAUT)
Contrasting Mettler-Toledo International (NYSE:MTD) and Nautilus Biotechnology (NASDAQ:NAUT)
Mettler-Toledo International (NYSE:MTD – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.
梅特勒-託萊多國際(NYSE：MTD-GET Rating)和鸚鵡螺生物科技(Nautilus Biotech)(納斯達克：NAUT-GET Rating)都是計算機和科技公司，但哪項業務更優越？我們將根據兩家公司的盈利能力、股息、收益、風險、分析師建議、估值和機構持股的強項對兩家公司進行比較。
Institutional and Insider Ownership
機構和內部人持股
91.9% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 45.3% of Nautilus Biotechnology shares are owned by institutional investors. 2.8% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 41.3% of Nautilus Biotechnology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
梅特勒-託萊多國際公司91.9%的股份由機構投資者持有。相比之下，機構投資者持有鸚鵡螺生物技術公司45.3%的股份。梅特勒-託萊多國際公司2.8%的股份由公司內部人士持有。相比之下，鸚鵡螺生物技術公司41.3%的股份由公司內部人士持有。強大的機構持股表明，大型基金管理公司、捐贈基金和對衝基金相信，一家公司有望實現長期增長。
Profitability
盈利能力
This table compares Mettler-Toledo International and Nautilus Biotechnology's net margins, return on equity and return on assets.
該表比較了梅特勒-託萊多國際公司和鸚鵡螺生物技術公司的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.48% | 1,929.28% | 26.15% |
| Nautilus Biotechnology | N/A | -17.79% | -16.17% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| 梅特勒-託萊多國際 | 21.48% | 1,929.28% | 26.15% |
| 鸚鵡螺生物技術 | 不適用 | -17.79% | -16.17% |
Analyst Ratings
分析師評級
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 0 | 4 | 2 | 0 | 2.33 |
| Nautilus Biotechnology | 0 | 2 | 0 | 0 | 2.00 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| 梅特勒-託萊多國際 | 0 | 4 | 2 | 0 | 2.33 |
| 鸚鵡螺生物技術 | 0 | 2 | 0 | 0 | 2.00 |
Mettler-Toledo International currently has a consensus price target of $1,356.00, indicating a potential downside of 6.19%. Nautilus Biotechnology has a consensus price target of $4.00, indicating a potential upside of 122.22%. Given Nautilus Biotechnology's higher probable upside, analysts plainly believe Nautilus Biotechnology is more favorable than Mettler-Toledo International.
梅特勒-託萊多國際公司目前的普遍目標價為1,356.00美元，這意味着潛在的下行幅度為6.19%。鸚鵡螺生物技術公司的共識目標價為4.00美元，表明潛在上漲122.22。鑑於鸚鵡螺生物技術的上行可能性更高，分析師顯然認為鸚鵡螺生物技術公司比梅特勒-託萊多國際公司更有利。
Valuation and Earnings
估值和收益
This table compares Mettler-Toledo International and Nautilus Biotechnology's revenue, earnings per share (EPS) and valuation.
該表格比較了梅特勒-託萊多國際公司和鸚鵡螺生物科技公司的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $3.72 billion | 8.67 | $768.98 million | $36.54 | 39.56 |
| Nautilus Biotechnology | N/A | N/A | -$50.31 million | ($0.49) | -3.67 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 市盈率 | |
| 梅特勒-託萊多國際 | 37.2億美元 | 8.67 | 7.6898億美元 | $36.54 | 39.56 |
| 鸚鵡螺生物技術 | 不適用 | 不適用 | -5,031萬元 | ($0.49) | -3.67 |
Mettler-Toledo International has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
梅特勒-託萊多國際公司的收入和收益高於鸚鵡螺生物科技公司。鸚鵡螺生物科技的市盈率低於梅特勒-託萊多國際，表明它目前是兩隻股票中更負擔得起的一隻。
Risk & Volatility
風險與波動性
Mettler-Toledo International has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Nautilus Biotechnology has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.
梅特勒-託萊多國際的貝塔係數為1.21，這表明其股價的波動性比標準普爾500指數高出21%。相比之下，鸚鵡螺生物技術公司的貝塔係數為0.84，這表明其股價的波動性比標準普爾500指數低16%。
Summary
摘要
Mettler-Toledo International beats Nautilus Biotechnology on 11 of the 13 factors compared between the two stocks.
梅特勒-託萊多國際公司在比較兩隻股票的13個因素中有11個擊敗了鸚鵡螺生物科技公司。
About Mettler-Toledo International
關於梅特勒-託萊多國際公司
(Get Rating)
(獲取評級)
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
梅特勒-託萊多國際公司致力於在全球範圍內製造和供應精密儀器和服務。它分為五個部門：美國業務、瑞士業務、西歐業務、中國業務和其他業務。該公司的實驗室儀器包括實驗室天平、液體移液、自動化實驗室反應器、滴定儀、pH計、過程分析傳感器和分析技術、物理值分析儀、熱分析系統和其他分析儀器；以及LABX，這是一個管理和分析其儀器產生的數據的實驗室軟件平臺。其工業儀器包括工業稱重儀器及相關終端、自動尺寸測量和數據採集解決方案、車輛稱重系統、工業軟件、金屬檢測、X射線、校核稱重、基於相機的成像設備、跟蹤和跟蹤解決方案以及產品檢測系統。該公司的零售稱重解決方案包括聯網稱重和軟件、獨立稱重以及用於處理新鮮商品的自動化包裝和標籤解決方案。它通過其直銷隊伍和間接分銷渠道，為生命科學行業、獨立研究機構和檢測實驗室、食品和飲料製造商、食品零售商、化學、特種化學品和化粧品公司、食品零售商、運輸和物流、金屬和電子行業以及學術界提供服務。該公司成立於1991年，總部設在俄亥俄州哥倫布市。
About Nautilus Biotechnology
關於鸚鵡螺生物技術
(Get Rating)
(獲取評級)
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
鸚鵡螺生物技術公司是一家處於發展階段的生命科學公司，致力於創建一種量化和解鎖蛋白質組複雜性的平臺技術。它開發了Nautilus Platform，這是一個蛋白質組學平臺，包括由儀器、消耗品和軟件分析組成的端到端解決方案。該公司成立於2016年，總部位於華盛頓州西雅圖。
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
接受梅特勒-託萊多國際日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對梅特勒-託萊多國際公司和相關公司的最新新聞和分析師評級的每日簡要摘要。